Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

230720
Table 10.1A – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 18 or Older with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic AMONG ADULTS WHO HAD
SERIOUS THOUGHTS OF SUICIDE
AMONG ADULTS WHO MADE
ANY SUICIDE PLANS
AMONG ADULTS WHO
ATTEMPTED SUICIDE
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2021)
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2022)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2021)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2022)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2021)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2022)
TOTAL 1,989 1,961 473 435 284 216
AGE GROUP            
18-25 664 677 218 135 90 93
26 or Older 1,326 1,285 255 300 * 122
26-49 1,080 855 229 163 * 70
50 or Older 246 430 * * * *
GENDER            
Male 891 1,051 296 271 * 101
Female 1,099 910 177 164 89 115
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,620 1,629 322 315 156 173
AIAN * * * * * *
Asian 53 * * * * *
Black or African American 322 454 * * * *
NHOPI * * * * * *
White 1,116 912 216 139 76 72
Two or More Races * * * * * *
Hispanic or Latino 369 332 * * * *
EMPLOYMENT STATUS            
Full-Time 808 673 195 147 * 45
Part-Time 273 392 78 46 * *
Unemployed 312 238 * 66 * *
Other1 596 658 111 175 73 98
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.1B – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 18 or Older with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic AMONG ADULTS WHO HAD
SERIOUS THOUGHTS OF SUICIDE
AMONG ADULTS WHO MADE
ANY SUICIDE PLANS
AMONG ADULTS WHO
ATTEMPTED SUICIDE
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2021)
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2022)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2021)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2022)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2021)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2022)
TOTAL 15.9 14.9 13.1 11.6 15.7 13.3
AGE GROUP            
18-25 14.8 14.3 12.5 7.9 9.5 12.8
26 or Older 16.5 15.2 13.5 14.7 * 13.7
26-49 19.2 15.2 15.5 11.9 * 14.4
50 or Older 10.3 15.2 * * * *
GENDER            
Male 16.0 16.8 18.0 16.1 * 13.4
Female 15.8 13.1 8.9 7.9 8.6 13.2
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15.6 14.6 11.2 10.1 11.9 12.6
AIAN * * * * * *
Asian 13.9 * * * * *
Black or African American 22.6 26.7 * * * *
NHOPI * * * * * *
White 13.9 11.0 9.7 6.1 8.5 7.6
Two or More Races * * * * * *
Hispanic or Latino 17.5 16.2 * * * *
EMPLOYMENT STATUS            
Full-Time 15.9 12.2 15.8 10.6 * 9.6
Part-Time 12.4 15.2 11.9 5.4 * *
Unemployed 22.4 24.7 * 19.0 * *
Other1 15.5 15.9 9.2 15.1 11.4 13.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.2A – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 12 to 17 with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic AMONG YOUTHS WHO HAD
SERIOUS THOUGHTS OF SUICIDE
AMONG YOUTHS WHO MADE
ANY SUICIDE PLANS
AMONG YOUTHS WHO
ATTEMPTED SUICIDE
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2021)
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2022)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2021)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2022)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2021)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2022)
TOTAL 496 506 200 156 77 123
12-13 113 99 52 * 29 19
14-15 202 208 * 60 19 *
16-17 181 198 52 36 * *
GENDER            
Male 171 201 47 28 * *
Female 325 305 153 128 41 52
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 404 329 160 101 60 53
AIAN * * * * * *
Asian * * * * * *
Black or African American 70 69 * 22 * 14
NHOPI * * * * * *
White 259 227 92 72 37 24
Two or More Races * * * * * *
Hispanic or Latino 92 177 * * 16 *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their suicidal thoughts or behaviors because of the COVID-19 pandemic were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.2B – Had Serious Thoughts of Suicide Because of the COVID-19 Pandemic, Made Any Suicide Plans Because of the COVID-19 Pandemic, and Attempted Suicide Because of the COVID-19 Pandemic in Past Year: Among People Aged 12 to 17 with Respective Suicidal Thoughts and Behaviors in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic AMONG YOUTHS WHO HAD
SERIOUS THOUGHTS OF SUICIDE
AMONG YOUTHS WHO MADE
ANY SUICIDE PLANS
AMONG YOUTHS WHO
ATTEMPTED SUICIDE
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2021)
Had Serious
Thoughts of
Suicide Because of
the COVID-19
Pandemic
(2022)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2021)
Made Any Suicide
Plans Because of
the COVID-19
Pandemic
(2022)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2021)
Attempted Suicide
Because of the
COVID-19
Pandemic
(2022)
TOTAL 15.2 15.2 12.7 9.5 8.4 12.9
12-13 13.3 13.1 11.3 * 9.8 7.6
14-15 18.0 15.6 * 9.1 5.9 *
16-17 13.9 16.2 9.0 6.5 * *
GENDER            
Male 16.0 17.9 10.4 6.0 * *
Female 14.8 13.9 13.7 10.9 6.6 7.9
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 16.5 13.1 14.5a 7.9 9.4 7.5
AIAN * * * * * *
Asian * * * * * *
Black or African American 17.2 16.7 * 8.8 * 8.5
NHOPI * * * * * *
White 15.7 12.9 12.2 8.3 9.5 5.4
Two or More Races * * * * * *
Hispanic or Latino 11.2a 22.0 * * 5.9 *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their suicidal thoughts or behaviors because of the COVID-19 pandemic were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.3A – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Drugs a
Little Less or
Much Less
than before the
Pandemic
(2022)
Used Drugs
about the Same
as before the
Pandemic
(2021)
Used Drugs
about the Same
as before the
Pandemic
(2022)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2021)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 40,578 42,055 56,393b 62,462 10,473 11,142
AGE GROUP            
12-17 2,763a 2,373 1,786 2,002 641b 865
18 or Older 37,815 39,682 54,606b 60,460 9,831 10,276
18-25 5,649 5,629 7,112b 8,108 2,596b 3,191
26 or Older 32,166 34,053 47,495b 52,353 7,236 7,085
GENDER            
Male 19,615 20,840 26,887b 30,698 4,842 5,477
Female 20,963 21,215 29,506a 31,764 5,630 5,665
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 33,516 33,884 50,449b 55,533 8,914 9,329
AIAN 437 404 402a 206 107a 41
Asian 1,531 1,496 1,369b 2,119 273 348
Black or African American 6,566 6,859 5,258 5,513 1,496 1,170
NHOPI * * * * * *
White 23,483 23,806 42,048b 46,089 6,735 7,413
Two or More Races 1,147 1,048 1,248 1,513 275 297
Hispanic or Latino 7,062 8,170 5,943a 6,929 1,558 1,813
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded.
NOTE: Drug use includes the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.3B – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Drugs a
Little Less or
Much Less
than before the
Pandemic
(2022)
Used Drugs
about the Same
as before the
Pandemic
(2021)
Used Drugs
about the Same
as before the
Pandemic
(2022)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2021)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 37.8 36.4 52.5 54.0 9.7 9.6
AGE GROUP            
12-17 53.2b 45.3 34.4 38.2 12.4b 16.5
18 or Older 37.0 35.9 53.4 54.8 9.6 9.3
18-25 36.8b 33.3 46.3 47.9 16.9 18.8
26 or Older 37.0 36.4 54.7 56.0 8.3 7.6
GENDER            
Male 38.2 36.6 52.4 53.8 9.4 9.6
Female 37.4 36.2 52.6 54.2 10.0 9.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 36.1 34.3 54.3a 56.2 9.6 9.4
AIAN 46.2a 62.0 42.5 31.7 11.3 6.3
Asian 48.3a 37.8 43.1 53.5 8.6 8.8
Black or African American 49.3 50.7 39.5 40.7 11.2a 8.6
NHOPI * * * * * *
White 32.5 30.8 58.2 59.6 9.3 9.6
Two or More Races 43.0 36.7 46.7 52.9 10.3 10.4
Hispanic or Latino 48.5 48.3 40.8 41.0 10.7 10.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded.
NOTE: Drug use includes the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.4A – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Drugs
about the Same
as before the
Pandemic
(2021)
Used Drugs
about the Same
as before the
Pandemic
(2022)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2021)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 40,578 42,055 56,393b 62,462 10,473 11,142
GEOGRAPHIC REGION            
Northeast 5,843 6,748 9,411 10,770 2,301 1,975
Midwest 8,420 8,546 13,087 13,942 2,089 2,415
South 16,512 16,769 20,029 21,986 3,090 3,455
West 9,803 9,992 13,866a 15,764 2,992 3,297
COUNTY TYPE            
Large Metro 20,509 22,100 29,363b 33,798 6,262 6,493
Small Metro 12,799 13,819 18,706 20,425 3,237 3,589
Nonmetro 7,270 6,136 8,324 8,238 973 1,059
Urbanized 2,707 2,498 3,339 3,493 439 564
Less Urbanized 3,794 3,129 4,210 4,046 465 451
Completely Rural 769 * 775 * 70 45
POVERTY LEVEL1            
Less Than 100% 8,695 8,253 6,736 6,728 1,952 1,733
100-199% 9,536 10,559 10,377 10,635 2,213 2,128
200% or More 22,346 23,242 39,268b 45,097 6,302a 7,280
HEALTH INSURANCE2            
Private 20,221 21,462 36,466b 41,024 6,011a 7,062
Medicaid/CHIP 12,258 12,091 9,779a 11,077 2,978 2,667
Other3 12,784 13,764 14,790 16,048 1,823 1,704
No Coverage 4,140 3,748 4,600 4,473 883 935
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded.
NOTE: Drug use includes the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.4B – Perceived COVID-19 Pandemic Effect on Drug Use: Among Past Year Drug Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Drugs a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Drugs
about the Same
as before the
Pandemic
(2021)
Used Drugs
about the Same
as before the
Pandemic
(2022)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2021)
Used Drugs a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 37.8 36.4 52.5 54.0 9.7 9.6
GEOGRAPHIC REGION            
Northeast 33.3 34.6 53.6 55.3 13.1a 10.1
Midwest 35.7 34.3 55.5 56.0 8.9 9.7
South 41.7 39.7 50.5 52.1 7.8 8.2
West 36.8 34.4 52.0 54.3 11.2 11.3
COUNTY TYPE            
Large Metro 36.5 35.4 52.3 54.2 11.2 10.4
Small Metro 36.8 36.5 53.8 54.0 9.3 9.5
Nonmetro 43.9 39.8 50.2 53.4 5.9 6.9
Urbanized 41.7 38.1 51.5 53.3 6.8 8.6
Less Urbanized 44.8 41.0 49.7 53.1 5.5 5.9
Completely Rural 47.7 * 48.0 * 4.3 3.6
POVERTY LEVEL1            
Less Than 100% 50.0 49.4 38.7 40.3 11.2 10.4
100-199% 43.1 45.3 46.9 45.6 10.0 9.1
200% or More 32.9a 30.7 57.8 59.6 9.3 9.6
HEALTH INSURANCE2            
Private 32.3 30.9 58.2 59.0 9.6 10.2
Medicaid/CHIP 49.0 46.8 39.1a 42.9 11.9 10.3
Other3 43.5 43.7 50.3 50.9 6.2 5.4
No Coverage 43.0 40.9 47.8 48.9 9.2 10.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their drug use were excluded.
NOTE: Drug use includes the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.5A – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Alcohol
about the Same as
before the
Pandemic
(2021)
Used Alcohol
about the Same as
before the
Pandemic
(2022)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2021)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 50,466 47,597 94,774b 103,821 22,437b 19,435
AGE GROUP            
12-201 3,899b 3,131 4,693 4,868 1,565 1,650
21 or Older1 46,567 44,466 90,081b 98,953 20,872b 17,785
12-17 1,684b 1,286 1,672 1,563 628 644
18 or Older 48,783 46,311 93,102b 102,258 21,809b 18,791
18-25 7,247 6,594 11,222 12,163 3,208 3,588
26 or Older 41,535 39,718 81,880b 90,095 18,601b 15,203
GENDER            
Male 25,622 23,833 47,739b 52,881 10,706 9,582
Female 24,845 23,764 47,035b 50,940 11,731b 9,853
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 38,778a 35,523 83,004b 90,021 19,474b 17,083
AIAN * 260 * 326 98 81
Asian 2,410 2,421 3,846a 4,798 897 660
Black or African American 7,168 6,880 8,714 8,940 2,082 2,171
NHOPI * * * * * *
White 27,486b 24,612 67,998b 73,853 15,855b 13,696
Two or More Races 974 1,046 1,768 1,905 510 425
Hispanic or Latino 11,689 12,074 11,769a 13,800 2,962 2,352
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.5B – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Alcohol
about the Same as
before the
Pandemic
(2021)
Used Alcohol
about the Same as
before the
Pandemic
(2022)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2021)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 30.1b 27.9 56.5b 60.8 13.4b 11.4
AGE GROUP            
12-201 38.4b 32.4 46.2a 50.4 15.4 17.1
21 or Older1 29.6b 27.6 57.2b 61.4 13.3b 11.0
12-17 42.3 36.8 42.0 44.8 15.8 18.4
18 or Older 29.8b 27.7 56.9b 61.1 13.3b 11.2
18-25 33.4b 29.5 51.8a 54.4 14.8 16.1
26 or Older 29.2a 27.4 57.7b 62.1 13.1b 10.5
GENDER            
Male 30.5b 27.6 56.8b 61.3 12.7a 11.1
Female 29.7 28.1 56.3b 60.2 14.0b 11.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 27.5b 24.9 58.8b 63.1 13.8b 12.0
AIAN * 38.9 * 48.9 9.8 12.2
Asian 33.7 30.7 53.8a 60.9 12.5 8.4
Black or African American 39.9 38.2 48.5 49.7 11.6 12.1
NHOPI * * * * * *
White 24.7b 21.9 61.1b 65.8 14.2b 12.2
Two or More Races 30.0 31.0 54.4 56.4 15.7 12.6
Hispanic or Latino 44.2 42.8 44.5a 48.9 11.2b 8.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.6A – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Alcohol
about the Same as
before the
Pandemic
(2021)
Used Alcohol
about the Same as
before the
Pandemic
(2022)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2021)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 50,466 47,597 94,774b 103,821 22,437b 19,435
GEOGRAPHIC REGION            
Northeast 8,242 8,444 17,602 19,497 4,169 3,801
Midwest 10,763 9,709 22,063 23,410 4,748 4,187
South 18,906 17,760 35,468 37,585 7,232 6,239
West 12,556 11,684 19,641b 23,330 6,288 5,207
COUNTY TYPE            
Large Metro 27,819 27,272 49,966b 57,254 13,918a 11,941
Small Metro 15,199 14,542 30,485a 33,535 6,343 5,858
Nonmetro 7,449b 5,783 14,323 13,032 2,175a 1,636
Urbanized 2,681 2,516 5,700 5,650 939 815
Less Urbanized 3,938a 2,885 7,447 6,243 1,078 747
Completely Rural 830a 383 1,176 1,139 158a 74
POVERTY LEVEL1            
Less Than 100% 8,554 7,743 8,274 8,027 2,139 2,017
100-199% 10,411 10,384 14,744 14,831 2,819 2,721
200% or More 31,501 29,470 71,729b 80,961 17,476b 14,695
HEALTH INSURANCE2            
Private 29,552a 27,025 66,412b 73,025 16,006a 14,362
Medicaid/CHIP 11,206 10,498 11,202a 12,630 2,981 2,709
Other3 12,727 12,632 25,156a 27,805 3,279 2,802
No Coverage 5,481 5,224 7,528 7,061 1,976b 1,299
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.6B – Perceived COVID-19 Pandemic Effect on Alcohol Use: Among Past Year Alcohol Users Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2021)
Used Alcohol a
Little Less or
Much Less than
before the
Pandemic
(2022)
Used Alcohol
about the Same as
before the
Pandemic
(2021)
Used Alcohol
about the Same as
before the
Pandemic
(2022)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2021)
Used Alcohol a
Little More or
Much More than
before the
Pandemic
(2022)
TOTAL 30.1b 27.9 56.5b 60.8 13.4b 11.4
GEOGRAPHIC REGION            
Northeast 27.5 26.6 58.6 61.4 13.9 12.0
Midwest 28.6a 26.0 58.7b 62.8 12.6 11.2
South 30.7 28.8 57.6b 61.0 11.7a 10.1
West 32.6a 29.0 51.0b 58.0 16.3b 12.9
COUNTY TYPE            
Large Metro 30.3a 28.3 54.5b 59.4 15.2b 12.4
Small Metro 29.2a 27.0 58.6b 62.2 12.2 10.9
Nonmetro 31.1 28.3 59.8a 63.7 9.1 8.0
Urbanized 28.8 28.0 61.2 62.9 10.1 9.1
Less Urbanized 31.6 29.2 59.8 63.2 8.6 7.6
Completely Rural 38.4b 24.0 54.3b 71.4 7.3 4.6
POVERTY LEVEL1            
Less Than 100% 45.1 43.5 43.6 45.1 11.3 11.3
100-199% 37.2 37.2 52.7 53.1 10.1 9.7
200% or More 26.1b 23.6 59.4b 64.7 14.5b 11.7
HEALTH INSURANCE2            
Private 26.4b 23.6 59.3b 63.8 14.3b 12.6
Medicaid/CHIP 44.1a 40.6 44.1b 48.9 11.7 10.5
Other3 30.9 29.2 61.1a 64.3 8.0 6.5
No Coverage 36.6 38.5 50.2 52.0 13.2a 9.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their alcohol use were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.7A – Perceived COVID-19 Pandemic Effect on Access to Substance Use Treatment: Among People Aged 12 or Older, among People Aged 12 or Older with Drug or Alcohol Use in Past Year, and among People Aged 12 or Older with Substance Use Disorder in Past Year; by Age Group, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to Substance Use Treatment Aged 12+
(2021)
Aged 12+
(2022)
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 23,803b 19,064 1,527 1,280 22,276b 17,784 1,977 1,744 20,299b 16,040
Delays or cancellations in appointments 21,887b 18,302 2,236b 1,611 19,651b 16,691 1,877a 1,599 17,774b 15,092
Delays in getting prescriptions 10,391 9,482 827 749 9,564 8,733 957 827 8,607 7,906
Unable to access needed care resulting in moderate
   or severe impact on health
7,314 6,657 519 410 6,795 6,247 724 576 6,071 5,671
PERCEIVED EFFECT AMONG PAST YEAR DRUG OR
ALCOHOL USERS
                   
Appointments moved from in-person to telehealth 15,223b 12,829 465 337 14,758b 12,493 1,466 1,354 13,292b 11,138
Delays or cancellations in appointments 13,293a 11,751 612b 322 12,681 11,428 1,342 1,216 11,339 10,212
Delays in getting prescriptions 6,227 6,215 299a 176 5,927 6,039 694 635 5,233 5,405
Unable to access needed care resulting in moderate
   or severe impact on health
4,415 4,435 214 135 4,201 4,300 538 419 3,663 3,881
PERCEIVED EFFECT AMONG PEOPLE WITH PAST
YEAR SUBSTANCE USE DISORDER1
                   
Appointments moved from in-person to telehealth 5,648 5,244 293 224 5,354 5,020 717 685 4,638 4,335
Delays or cancellations in appointments 5,109 4,765 314b 166 4,795 4,599 604 592 4,192 4,007
Delays in getting prescriptions 3,021 3,055 219a 111 2,802 2,944 363 329 2,439 2,615
Unable to access needed care resulting in moderate
   or severe impact on health
2,442 2,291 164 87 2,278 2,203 293 228 1,985 1,975
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to substance use treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their access to substance use treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.7B – Perceived COVID-19 Pandemic Effect on Access to Substance Use Treatment: Among People Aged 12 or Older, among People Aged 12 or Older with Drug or Alcohol Use in Past Year, and among People Aged 12 or Older with Substance Use Disorder in Past Year; by Age Group, Percentages, 2021 and 2022
Perceived Effect on Access to Substance Use Treatment Aged 12+
(2021)
Aged 12+
(2022)
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 8.7b 6.9 6.2 5.2 8.9b 7.0 6.0a 5.1 9.4b 7.3
Delays or cancellations in appointments 8.0b 6.6 9.0b 6.6 7.9b 6.6 5.7a 4.7 8.2b 6.9
Delays in getting prescriptions 3.8 3.4 3.3 3.1 3.8 3.5 2.9 2.4 4.0 3.6
Unable to access needed care resulting in moderate
   or severe impact on health
2.7 2.4 2.1 1.7 2.7 2.5 2.2a 1.7 2.8 2.6
PERCEIVED EFFECT AMONG PAST YEAR DRUG OR
ALCOHOL USERS
                   
Appointments moved from in-person to telehealth 8.4b 6.9 7.7 6.0 8.4b 6.9 6.2 5.5 8.7b 7.2
Delays or cancellations in appointments 7.3b 6.3 10.2b 5.7 7.2a 6.3 5.6 4.9 7.5a 6.6
Delays in getting prescriptions 3.4 3.3 5.0a 3.1 3.4 3.4 2.9 2.6 3.4 3.5
Unable to access needed care resulting in moderate
   or severe impact on health
2.4 2.4 3.6 2.4 2.4 2.4 2.3 1.7 2.4 2.5
PERCEIVED EFFECT AMONG PEOPLE WITH PAST
YEAR SUBSTANCE USE DISORDER1
                   
Appointments moved from in-person to telehealth 12.4 11.1 12.8 10.8 12.4 11.1 8.3 7.2 13.4 12.1
Delays or cancellations in appointments 11.2 10.0 13.7a 8.0 11.1 10.1 7.0 6.2 12.1 11.2
Delays in getting prescriptions 6.6 6.4 9.6a 5.3 6.5 6.5 4.2 3.5 7.0 7.3
Unable to access needed care resulting in moderate
   or severe impact on health
5.4 4.8 7.2 4.2 5.3 4.9 3.4 2.4 5.7 5.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to substance use treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their access to substance use treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.8A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
                   
Not at all 90,787b 101,918 10,659b 11,716 80,128b 90,201 35,499b 38,159 44,628b 52,043
A little or some 123,669b 118,328 15,195a 15,960 108,475b 102,369 48,079 46,940 60,396b 55,428
Quite a bit or a lot 35,835b 32,685 7,117a 6,538 28,718b 26,147 17,294a 15,892 11,424 10,255
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE
                   
Not at all 2,675b 3,541 652b 984 2,022 2,557 1,236 1,539 786 1,018
A little or some 9,047 9,717 2,492b 3,186 6,555 6,531 4,054 4,154 2,500 2,377
Quite a bit or a lot 9,537 9,011 3,192 2,726 6,345 6,285 4,414 4,173 1,930 2,112
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE WITH SEVERE
IMPAIRMENT
                   
Not at all 1,757b 2,519 406b 666 1,351a 1,853 788a 1,150 563 703
A little or some 5,839 6,389 1,632b 2,219 4,208 4,170 2,590 2,719 1,617 1,451
Quite a bit or a lot 7,043 6,854 2,455 2,158 4,587 4,695 3,360 3,149 1,227 1,546
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MDE
                   
Not at all 88,112b 98,377 10,007 10,732 78,105b 87,645 34,263 36,619 43,842b 51,025
A little or some 114,623a 108,612 12,702 12,774 101,920a 95,838 44,025 42,786 57,895a 53,052
Quite a bit or a lot 26,298b 23,674 3,925 3,812 22,373b 19,862 12,880 11,720 9,494 8,143
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.8B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
                   
Not at all 36.3b 40.3 32.3 34.2 36.9b 41.2 35.2b 37.8 38.3b 44.2
A little or some 49.4b 46.8 46.1 46.6 49.9b 46.8 47.7 46.5 51.9b 47.1
Quite a bit or a lot 14.3b 12.9 21.6b 19.1 13.2b 12.0 17.1a 15.7 9.8 8.7
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE
                   
Not at all 12.6b 15.9 10.3b 14.3 13.6 16.6 12.7 15.6 15.1 18.5
A little or some 42.6 43.6 39.3b 46.2 43.9 42.5 41.8 42.1 47.9 43.2
Quite a bit or a lot 44.9b 40.5 50.4b 39.5 42.5 40.9 45.5 42.3 37.0 38.4
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE WITH SEVERE
IMPAIRMENT
                   
Not at all 12.0b 16.0 9.0a 13.2 13.3 17.3 11.7a 16.4 16.5 19.0
A little or some 39.9 40.5 36.3b 44.0 41.5 38.9 38.4 38.7 47.5 39.2
Quite a bit or a lot 48.1a 43.5 54.7b 42.8 45.2 43.8 49.9 44.9 36.0 41.8
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MDE
                   
Not at all 38.5b 42.6 37.6 39.3 38.6b 43.1 37.6b 40.2 39.4b 45.5
A little or some 50.0b 47.1 47.7 46.8 50.4b 47.1 48.3 47.0 52.0b 47.3
Quite a bit or a lot 11.5b 10.3 14.7 14.0 11.1b 9.8 14.1a 12.9 8.5a 7.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.9A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Numbers in Thousands, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
                   
Not at all 90,787b 101,918 10,659b 11,716 80,128b 90,201 35,499b 38,159 44,628b 52,043
A little or some 123,669b 118,328 15,195a 15,960 108,475b 102,369 48,079 46,940 60,396b 55,428
Quite a bit or a lot 35,835b 32,685 7,117a 6,538 28,718b 26,147 17,294a 15,892 11,424 10,255
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR ANY MENTAL ILLNESS
                   
Not at all 9,516b 11,694 1,583b 1,985 7,933b 9,709 4,527b 5,573 3,406 4,136
A little or some 27,323 27,820 5,045b 5,898 22,278 21,922 13,163 14,138 9,115 7,784
Quite a bit or a lot 20,499a 18,767 4,666 4,426 15,833a 14,341 10,917a 9,859 4,916 4,482
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR SERIOUS MENTAL ILLNESS
                   
Not at all 1,682b 2,685 392b 604 1,290b 2,081 906 1,225 384a 856
A little or some 5,819 6,187 1,482a 1,829 4,337 4,359 2,886 3,176 1,451 1,182
Quite a bit or a lot 6,890 6,373 2,068b 1,550 4,822 4,823 3,635 3,349 1,187 1,474
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MENTAL ILLNESS
                   
Not at all 81,271b 90,224 9,076 9,731 72,195b 80,492 30,972 32,585 41,223b 47,907
A little or some 96,346a 90,508 10,149 10,062 86,197a 80,446 34,916 32,802 51,281a 47,644
Quite a bit or a lot 15,336 13,918 2,451 2,112 12,885 11,806 6,376 6,033 6,509 5,773
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.9B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Percentages, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
                   
Not at all 36.3b 40.3 32.3 34.2 36.9b 41.2 35.2b 37.8 38.3b 44.2
A little or some 49.4b 46.8 46.1 46.6 49.9b 46.8 47.7 46.5 51.9b 47.1
Quite a bit or a lot 14.3b 12.9 21.6b 19.1 13.2b 12.0 17.1a 15.7 9.8 8.7
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR ANY MENTAL ILLNESS
                   
Not at all 16.6b 20.1 14.0 16.1 17.2b 21.1 15.8b 18.8 19.5a 25.2
A little or some 47.7 47.7 44.7a 47.9 48.4 47.7 46.0 47.8 52.3 47.5
Quite a bit or a lot 35.8b 32.2 41.3b 36.0 34.4b 31.2 38.2b 33.3 28.2 27.3
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR SERIOUS MENTAL ILLNESS
                   
Not at all 11.7b 17.6 10.0b 15.2 12.3b 18.5 12.2 15.8 12.7a 24.4
A little or some 40.4 40.6 37.6b 45.9 41.5 38.7 38.9 41.0 48.0a 33.7
Quite a bit or a lot 47.9b 41.8 52.5b 38.9 46.1 42.8 48.9a 43.2 39.3 42.0
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MENTAL ILLNESS
                   
Not at all 42.1b 46.4 41.9 44.4 42.2b 46.6 42.9b 45.6 41.6b 47.3
A little or some 49.9b 46.5 46.8 45.9 50.3b 46.6 48.3a 45.9 51.8b 47.0
Quite a bit or a lot 7.9a 7.2 11.3a 9.6 7.5 6.8 8.8 8.4 6.6 5.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.10A – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
               
Not at all 8,687b 9,745 3,292a 3,766 2,970 3,321 2,426 2,658
A little or some 11,885a 11,240 4,044a 3,527 3,777 4,021 4,065 3,692
Quite a bit or a lot 4,881b 4,124 1,263b 914 1,659 1,535 1,959 1,676
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE1
               
Not at all 610 692 173 175 212 241 225 277
A little or some 2,260 2,114 480 453 701 809 1,079a 852
Quite a bit or a lot 2,285 1,987 465 394 837 816 982a 777
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE WITH SEVERE
IMPAIRMENT1,2
               
Not at all 413 448 94 99 153 159 165 190
A little or some 1,446 1,418 270 255 476 556 700 607
Quite a bit or a lot 1,896 1,705 415 356 714 693 767 656
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MDE1
               
Not at all 7,858a 8,805 3,030a 3,450 2,671 3,014 2,158 2,341
A little or some 9,247 8,796 3,349a 2,901 2,997 3,114 2,901 2,782
Quite a bit or a lot 2,417a 1,995 717b 437 753 679 948 878
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.10B – Perceived COVID-19 Pandemic Negative Effect on Emotional or Mental Health: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021 and 2022
Perceived Negative Effect on Emotional or
Mental Health
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
TOTAL POPULATION
               
Not at all 34.1b 38.8 38.3b 45.9 35.3 37.4 28.7a 33.1
A little or some 46.7 44.8 47.0a 43.0 44.9 45.3 48.1 46.0
Quite a bit or a lot 19.2b 16.4 14.7b 11.1 19.7 17.3 23.2 20.9
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE1
               
Not at all 11.8 14.4 15.4 17.1 12.1 12.9 9.8a 14.5
A little or some 43.9 44.1 42.9 44.3 40.1 43.4 47.2 44.7
Quite a bit or a lot 44.3 41.4 41.6 38.6 47.8 43.7 43.0 40.8
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH PAST YEAR MDE WITH SEVERE
IMPAIRMENT1,2
               
Not at all 11.0 12.5 12.1 13.9 11.4 11.3 10.1 13.1
A little or some 38.5 39.7 34.6 35.9 35.4 39.5 42.9 41.8
Quite a bit or a lot 50.5 47.7 53.3 50.2 53.2 49.2 47.0 45.1
PERCEPTION OF PANDEMIC’S NEGATIVE EFFECT
ON EMOTIONAL OR MENTAL HEALTH AMONG
PEOPLE WITH NO PAST YEAR MDE1
               
Not at all 40.3b 44.9 42.7b 50.8 41.6 44.3 35.9 39.0
A little or some 47.4a 44.9 47.2a 42.7 46.7 45.7 48.3 46.4
Quite a bit or a lot 12.4b 10.2 10.1b 6.4 11.7 10.0 15.8 14.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s negative effect on their emotional or mental health were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.11A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 18 or Older; by Age Group and Past Year Mental Health Treatment Status, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to Mental
Health Treatment
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 52,399a 49,461 6,852 7,268 45,547b 42,193 24,221 22,941 21,327a 19,252
Delays or cancellations in appointments 47,337b 42,608 5,795 5,907 41,542b 36,701 20,236b 18,585 21,305b 18,116
Delays in getting prescriptions 17,794 18,089 2,284 2,611 15,510 15,478 8,171 8,457 7,339 7,021
Unable to access needed care resulting in moderate
   or severe impact on health
12,021 11,984 1,871 1,872 10,150 10,112 5,873 5,967 4,278 4,145
PERCEIVED EFFECT AMONG PEOPLE WHO
RECEIVED MENTAL HEALTH TREATMENT
IN PAST YEAR1
                   
Appointments moved from in-person to telehealth -- 28,244 -- 5,056 -- 23,188 -- 13,908 -- 9,281
Delays or cancellations in appointments -- 19,367 -- 3,526 -- 15,841 -- 9,155 -- 6,687
Delays in getting prescriptions -- 9,725 -- 1,808 -- 7,918 -- 4,839 -- 3,079
Unable to access needed care resulting in moderate
   or severe impact on health
-- 6,062 -- 1,221 -- 4,840 -- 3,028 -- 1,812
PERCEIVED EFFECT AMONG PEOPLE WHO
DID NOT RECEIVE MENTAL HEALTH
TREATMENT IN PAST YEAR1
                   
Appointments moved from in-person to telehealth -- 21,217 -- 2,213 -- 19,004 -- 9,033 -- 9,972
Delays or cancellations in appointments -- 23,241 -- 2,381 -- 20,860 -- 9,431 -- 11,429
Delays in getting prescriptions -- 8,364 -- 803 -- 7,560 -- 3,618 -- 3,942
Unable to access needed care resulting in moderate
   or severe impact on health
-- 5,922 -- 650 -- 5,271 -- 2,938 -- 2,333
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.11B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 18 or Older; by Age Group and Past Year Mental Health Treatment Status, Percentages, 2021 and 2022
Perceived Effect on Access to Mental
Health Treatment
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 21.0b 19.6 20.8 21.2 21.0b 19.3 24.1a 22.7 18.4a 16.4
Delays or cancellations in appointments 18.9b 16.9 17.6 17.3 19.1b 16.8 20.1b 18.4 18.3b 15.4
Delays in getting prescriptions 7.1 7.2 6.9 7.6 7.1 7.1 8.1 8.4 6.3 6.0
Unable to access needed care resulting in moderate
   or severe impact on health
4.8 4.7 5.7 5.5 4.7 4.6 5.8 5.9 3.7 3.5
PERCEIVED EFFECT AMONG PEOPLE WHO
RECEIVED MENTAL HEALTH TREATMENT
IN PAST YEAR1
                   
Appointments moved from in-person to telehealth -- 51.2 -- 55.2 -- 50.4 -- 55.7 -- 44.1
Delays or cancellations in appointments -- 35.1 -- 38.6 -- 34.5 -- 36.7 -- 31.8
Delays in getting prescriptions -- 17.6 -- 19.7 -- 17.2 -- 19.4 -- 14.7
Unable to access needed care resulting in moderate
   or severe impact on health
-- 11.0 -- 13.4 -- 10.5 -- 12.1 -- 8.6
PERCEIVED EFFECT AMONG PEOPLE WHO
DID NOT RECEIVE MENTAL HEALTH
TREATMENT IN PAST YEAR1
                   
Appointments moved from in-person to telehealth -- 10.8 -- 8.8 -- 11.0 -- 11.9 -- 10.4
Delays or cancellations in appointments -- 11.8 -- 9.5 -- 12.1 -- 12.4 -- 11.9
Delays in getting prescriptions -- 4.2 -- 3.2 -- 4.4 -- 4.8 -- 4.1
Unable to access needed care resulting in moderate
   or severe impact on health
-- 3.0 -- 2.6 -- 3.1 -- 3.9 -- 2.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.12A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 52,399a 49,461 6,852 7,268 45,547b 42,193 24,221 22,941 21,327a 19,252
Delays or cancellations in appointments 47,337b 42,608 5,795 5,907 41,542b 36,701 20,236b 18,585 21,305b 18,116
Delays in getting prescriptions 17,794 18,089 2,284 2,611 15,510 15,478 8,171 8,457 7,339 7,021
Unable to access needed care resulting in moderate
   or severe impact on health
12,021 11,984 1,871 1,872 10,150 10,112 5,873 5,967 4,278 4,145
PERCEIVED EFFECT AMONG ADULTS WITH PAST
YEAR ANY MENTAL ILLNESS
                   
Appointments moved from in-person to telehealth 22,219 22,373 3,984 4,496 18,235 17,877 11,817 11,739 6,418 6,139
Delays or cancellations in appointments 18,232 17,872 3,263 3,530 14,969 14,342 9,303 8,957 5,666 5,386
Delays in getting prescriptions 8,319a 9,456 1,468 1,731 6,851 7,725 4,054a 4,754 2,797 2,971
Unable to access needed care resulting in moderate
   or severe impact on health
6,301 6,689 1,319 1,306 4,982 5,382 3,260 3,674 1,723 1,709
PERCEIVED EFFECT AMONG ADULTS WITH PAST
YEAR SERIOUS MENTAL ILLNESS
                   
Appointments moved from in-person to telehealth 7,644 7,943 1,896 1,818 5,748 6,125 4,165 4,143 1,582 1,982
Delays or cancellations in appointments 5,939 6,659 1,551 1,437 4,388a 5,223 3,121 3,449 1,267 1,773
Delays in getting prescriptions 3,237 3,867 763 773 2,474 3,094 1,638 1,952 836 1,142
Unable to access needed care resulting in moderate
   or severe impact on health
2,878 3,097 769 723 2,108 2,374 1,517 1,610 591 764
PERCEIVED EFFECT AMONG ADULTS WITH NO
PAST YEAR MENTAL ILLNESS1
                   
Appointments moved from in-person to telehealth 30,180b 27,088 2,868 2,772 27,312b 24,315 12,403 11,202 14,909a 13,114
Delays or cancellations in appointments 29,105b 24,736 2,532 2,378 26,573b 22,359 10,934a 9,629 15,639b 12,730
Delays in getting prescriptions 9,475 8,633 816 880 8,659 7,753 4,118 3,703 4,542 4,050
Unable to access needed care resulting in moderate
   or severe impact on health
5,720 5,295 552 565 5,168 4,729 2,613 2,293 2,555 2,437
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.12B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 18 or Older; by Age Group and Past Year Level of Mental Illness, Percentages, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                    
Appointments moved from in-person to telehealth 21.0b 19.6 20.8 21.2 21.0b 19.3 24.1a 22.7 18.4a 16.4
Delays or cancellations in appointments 18.9b 16.9 17.6 17.3 19.1b 16.8 20.1b 18.4 18.3b 15.4
Delays in getting prescriptions 7.1 7.2 6.9 7.6 7.1 7.1 8.1 8.4 6.3 6.0
Unable to access needed care resulting in moderate
   or severe impact on health
4.8 4.7 5.7 5.5 4.7 4.6 5.8 5.9 3.7 3.5
PERCEIVED EFFECT AMONG ADULTS WITH PAST
YEAR ANY MENTAL ILLNESS
                   
Appointments moved from in-person to telehealth 38.8 38.5 35.3 36.5 39.6 39.0 41.3 39.7 36.8 37.7
Delays or cancellations in appointments 31.8 30.7 28.9 28.7 32.5 31.2 32.5 30.2 32.5 33.0
Delays in getting prescriptions 14.5a 16.2 13.0 14.1 14.9a 16.8 14.2 16.1 16.1 18.2
Unable to access needed care resulting in moderate
   or severe impact on health
11.0 11.5 11.7 10.6 10.8 11.7 11.4 12.4 9.9 10.5
PERCEIVED EFFECT AMONG ADULTS WITH PAST
YEAR SERIOUS MENTAL ILLNESS
                   
Appointments moved from in-person to telehealth 53.2 52.4 48.0 45.8 55.2 54.7 56.4 53.4 52.4 57.6
Delays or cancellations in appointments 41.4 43.7 39.3 36.2 42.2 46.4 42.2 44.4 42.0 50.7
Delays in getting prescriptions 22.5 25.5 19.3 19.5 23.8 27.7 22.2 25.2 27.7 33.2
Unable to access needed care resulting in moderate
   or severe impact on health
20.1 20.4 19.5 18.2 20.3 21.2 20.5 20.8 19.6 22.2
PERCEIVED EFFECT AMONG ADULTS WITH NO
PAST YEAR MENTAL ILLNESS1
                   
Appointments moved from in-person to telehealth 15.7b 13.9 13.3 12.7 16.0b 14.1 17.2a 15.7 15.1b 13.0
Delays or cancellations in appointments 15.1b 12.7 11.7 10.9 15.5b 13.0 15.1a 13.5 15.8b 12.6
Delays in getting prescriptions 4.9 4.4 3.8 4.0 5.1 4.5 5.7 5.2 4.6 4.0
Unable to access needed care resulting in moderate
   or severe impact on health
3.0 2.7 2.6 2.6 3.0 2.7 3.6 3.2 2.6 2.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.13A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 12 to 17; by Age Group and Past Year Mental Health Treatment Status, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                
Appointments moved from in-person to telehealth 3,523 3,224 895 746 1,178 1,205 1,450 1,273
Delays or cancellations in appointments 4,927b 3,892 1,509b 1,178 1,660 1,435 1,758b 1,280
Delays in getting prescriptions 1,427 1,316 393 359 484 515 550 443
Unable to access needed care resulting in moderate
   to severe impact on health
941 854 222 200 355 350 364 304
PERCEIVED EFFECT AMONG PEOPLE WHO
RECEIVED MENTAL HEALTH TREATMENT
IN PAST YEAR1
               
Appointments moved from in-person to telehealth -- 2,308 -- 532 -- 858 -- 919
Delays or cancellations in appointments -- 2,088 -- 587 -- 778 -- 723
Delays in getting prescriptions -- 883 -- 237 -- 350 -- 297
Unable to access needed care resulting in moderate
   to severe impact on health
-- 551 -- 128 -- 237 -- 187
PERCEIVED EFFECT AMONG PEOPLE WHO
DID NOT RECEIVE MENTAL HEALTH
TREATMENT IN PAST YEAR1
               
Appointments moved from in-person to telehealth -- 916 -- 214 -- 347 -- 355
Delays or cancellations in appointments -- 1,804 -- 591 -- 657 -- 557
Delays in getting prescriptions -- 433 -- 122 -- 165 -- 146
Unable to access needed care resulting in moderate
   to severe impact on health
-- 302 -- 73 -- 113 -- 117
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.13B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 12 to 17; by Age Group and Past Year Mental Health Treatment Status, Percentages, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                
Appointments moved from in-person to telehealth 14.2 13.1 11.0 9.5 14.3 13.8 17.2 16.0
Delays or cancellations in appointments 19.8b 15.8 18.5a 15.0 20.1b 16.4 20.9b 16.0
Delays in getting prescriptions 5.8 5.4 4.8 4.6 5.9 5.9 6.5 5.6
Unable to access needed care resulting in moderate
   to severe impact on health
3.8 3.5 2.7 2.6 4.3 4.0 4.3 3.8
PERCEIVED EFFECT AMONG PEOPLE WHO
RECEIVED MENTAL HEALTH TREATMENT
IN PAST YEAR1
               
Appointments moved from in-person to telehealth -- 31.6 -- 22.9 -- 32.1 -- 39.9
Delays or cancellations in appointments -- 28.5 -- 25.1 -- 29.2 -- 31.2
Delays in getting prescriptions -- 12.1 -- 10.2 -- 13.2 -- 12.9
Unable to access needed care resulting in moderate
   to severe impact on health
-- 7.6 -- 5.5 -- 8.9 -- 8.1
PERCEIVED EFFECT AMONG PEOPLE WHO
DID NOT RECEIVE MENTAL HEALTH
TREATMENT IN PAST YEAR1
               
Appointments moved from in-person to telehealth -- 5.3 -- 3.9 -- 5.7 -- 6.3
Delays or cancellations in appointments -- 10.5 -- 10.7 -- 10.8 -- 9.8
Delays in getting prescriptions -- 2.5 -- 2.2 -- 2.7 -- 2.6
Unable to access needed care resulting in moderate
   to severe impact on health
-- 1.8 -- 1.3 -- 1.9 -- 2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.14A – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                
Appointments moved from in-person to telehealth 3,523 3,224 895 746 1,178 1,205 1,450 1,273
Delays or cancellations in appointments 4,927b 3,892 1,509b 1,178 1,660 1,435 1,758b 1,280
Delays in getting prescriptions 1,427 1,316 393 359 484 515 550 443
Unable to access needed care resulting in moderate
   or severe impact on health
941 854 222 200 355 350 364 304
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
MDE IN PAST YEAR1
               
Appointments moved from in-person to telehealth 1,286 1,315 183 211 451 543 652 561
Delays or cancellations in appointments 1,554 1,335 284 319 545 507 725b 509
Delays in getting prescriptions 446 553 104 110 166 247 176 196
Unable to access needed care resulting in moderate
   or severe impact on health
386 490 61 89 164 231 161 169
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
MDE WITH SEVERE IMPAIRMENT IN PAST YEAR1,2
               
Appointments moved from in-person to telehealth 997 1,089 154 166 363 446 480 477
Delays or cancellations in appointments 1,174 1,111 205 256 445 420 525 435
Delays in getting prescriptions 374 456 93 91 136 206 145 159
Unable to access needed care resulting in moderate
   or severe impact on health
322 451 56 82 140 210 126 159
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
NO MDE IN PAST YEAR1
               
Appointments moved from in-person to telehealth 2,105 1,858 658 517 689 641 758 699
Delays or cancellations in appointments 3,215b 2,481 1,138b 801 1,077 916 999a 764
Delays in getting prescriptions 939a 750 271 244 308 264 360a 242
Unable to access needed care resulting in moderate
   or severe impact on health
539b 350 158 99 183 117 198 134
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.14B – Perceived COVID-19 Pandemic Effect on Access to Mental Health Treatment: Among People Aged 12 to 17; by Age Group and Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021 and 2022
Perceived Effect on Access to Mental Health Treatment Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 12-13
(2021)
Aged 12-13
(2022)
Aged 14-15
(2021)
Aged 14-15
(2022)
Aged 16-17
(2021)
Aged 16-17
(2022)
PERCEIVED EFFECT AMONG TOTAL POPULATION                
Appointments moved from in-person to telehealth 14.2 13.1 11.0 9.5 14.3 13.8 17.2 16.0
Delays or cancellations in appointments 19.8b 15.8 18.5a 15.0 20.1b 16.4 20.9b 16.0
Delays in getting prescriptions 5.8 5.4 4.8 4.6 5.9 5.9 6.5 5.6
Unable to access needed care resulting in moderate
   or severe impact on health
3.8 3.5 2.7 2.6 4.3 4.0 4.3 3.8
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
MDE IN PAST YEAR1
               
Appointments moved from in-person to telehealth 25.6 27.9 17.8 21.2 26.3 29.4 28.5 29.9
Delays or cancellations in appointments 30.9 28.1 27.8 31.7 31.7 27.5 31.7 26.9
Delays in getting prescriptions 8.9a 11.8 10.0 11.0 9.7 13.5 7.7 10.5
Unable to access needed care resulting in moderate
   or severe impact on health
7.7 10.4 5.9 8.9 9.6 12.6 7.1 9.0
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
MDE WITH SEVERE IMPAIRMENT IN PAST YEAR1,2
               
Appointments moved from in-person to telehealth 27.1 31.0 21.1 24.0 27.5 32.1 29.5 33.4
Delays or cancellations in appointments 31.9 31.4 28.2 36.4 33.6 30.1 32.2 30.2
Delays in getting prescriptions 10.2 13.0 12.5 13.0 10.3 15.0 8.9 11.2
Unable to access needed care resulting in moderate
   or severe impact on health
8.8a 12.8 7.6 11.7 10.7 15.2 7.8 11.1
PERCEIVED EFFECT AMONG PEOPLE WHO HAD
NO MDE IN PAST YEAR1
               
Appointments moved from in-person to telehealth 11.1 9.7 9.8 7.9 10.9 9.6 12.7 11.7
Delays or cancellations in appointments 16.9b 12.9 16.8b 12.2 17.1a 13.6 16.7b 12.8
Delays in getting prescriptions 4.9a 3.9 4.0 3.7 4.9 3.9 6.0a 4.0
Unable to access needed care resulting in moderate
   or severe impact on health
2.8b 1.8 2.4 1.5 2.9 1.7 3.3 2.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to mental health treatment did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to mental health treatment were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
2 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.15A – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC Loss of
Permanent
Housing
Because of
Pandemic
(2021)
Loss of
Permanent
Housing
Because of
Pandemic
(2022)
All of the
Time or
Nearly All of
the Time
(2021)
All of the
Time or
Nearly All of
the Time
(2022)
Some of the
Time or
Rarely
(2021)
Some of the
Time or
Rarely
(2022)
Never
(2021)
Never
(2022)
TOTAL 42,912 41,554 122,327 122,240 109,478a 113,005 4,420 4,824
AGE GROUP                
12-20 4,109 3,955 15,132 14,420 18,514 18,989 581 589
21 or Older 38,803 37,599 107,195 107,821 90,964 94,016 3,839 4,236
12-17 2,022 2,028 9,083 8,813 13,866 13,844 266 366
18 or Older 40,890 39,526 113,244 113,428 95,612a 99,161 4,154 4,458
18-25 6,487 6,192 15,997 16,636 10,363b 11,310 790 822
26 or Older 34,403 33,334 97,247 96,791 85,249 87,851 3,364 3,636
GENDER                
Male 19,225 18,631 55,538 56,377 59,524 60,852 2,476 2,786
Female 23,688 22,923 66,788 65,864 49,954a 52,153 1,944 2,038
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 33,285 32,057 99,729 99,846 93,330 95,526 3,542 3,838
AIAN 467 327 892 633 447 499 65 62
Asian 2,047 2,184 8,186 8,034 5,804 6,472 128 66
Black or African American 8,276 7,823 14,539 14,277 10,482 11,336 1,009 1,192
NHOPI * * * * * * * 51
White 20,975 20,222 73,201 73,800 74,577 74,824 2,072 2,237
Two or More Races 1,136 1,182 2,478 2,719 1,730 1,848 211 230
Hispanic or Latino 9,627 9,497 22,598 22,394 16,148a 17,479 878 986
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.15B – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC Loss of
Permanent
Housing
Because of
Pandemic
(2021)
Loss of
Permanent
Housing
Because of
Pandemic
(2022)
All of the
Time or
Nearly All of
the Time
(2021)
All of the
Time or
Nearly All of
the Time
(2022)
Some of the
Time or
Rarely
(2021)
Some of the
Time or
Rarely
(2022)
Never
(2021)
Never
(2022)
TOTAL 15.6 15.0 44.5 44.2 39.9 40.8 1.6 1.7
AGE GROUP                
12-20 10.9 10.6 40.1 38.6 49.0a 50.8 1.5 1.6
21 or Older 16.4 15.7 45.2 45.0 38.4 39.3 1.6 1.8
12-17 8.1 8.2 36.4 35.7 55.5 56.1 1.0 1.5
18 or Older 16.4 15.7 45.3 45.0 38.3 39.3 1.7 1.8
18-25 19.7 18.1 48.7 48.7 31.5 33.1 2.4 2.4
26 or Older 15.9 15.3 44.8 44.4 39.3 40.3 1.5 1.7
GENDER                
Male 14.3 13.7 41.4 41.5 44.3 44.8 1.8 2.0
Female 16.9 16.3 47.6 46.7 35.6a 37.0 1.4 1.4
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 14.7 14.1 44.1 43.9 41.2 42.0 1.6 1.7
AIAN 25.8 22.4 49.4 43.4 24.8 34.2 3.6 4.3
Asian 12.8 13.1 51.0 48.1 36.2 38.8 0.8 0.4
Black or African American 24.9 23.4 43.7 42.7 31.5 33.9 3.0 3.5
NHOPI * * * * * * * 4.1
White 12.4 12.0 43.4 43.7 44.2 44.3 1.2 1.3
Two or More Races 21.3 20.6 46.4 47.3 32.4 32.1 3.9 4.0
Hispanic or Latino 19.9 19.2 46.7 45.4 33.4 35.4 1.8 2.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.16A – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC Loss of
Permanent
Housing
Because of
Pandemic
(2021)
Loss of
Permanent
Housing
Because of
Pandemic
(2022)
All of the
Time or
Nearly All of
the Time
(2021)
All of the
Time or
Nearly All of
the Time
(2022)
Some of the
Time or
Rarely
(2021)
Some of the
Time or
Rarely
(2022)
Never
(2021)
Never
(2022)
TOTAL 42,912 41,554 122,327 122,240 109,478a 113,005 4,420 4,824
GEOGRAPHIC REGION                
Northeast 7,376 7,172 21,280 21,002 19,412 19,924 460a 777
Midwest 7,364 7,016 25,275 25,593 24,547 24,692 926 848
South 17,272 17,218 46,408 46,041 40,767a 42,676 1,834 2,036
West 10,899 10,147 29,365 29,603 24,753 25,713 1,201 1,164
COUNTY TYPE                
Large Metro 22,580 23,295 67,273 67,687 57,565a 62,228 2,177 2,571
Small Metro 13,317 13,038 37,453 38,997 34,167 35,614 1,309 1,632
Nonmetro 7,015b 5,221 17,601 15,557 17,747a 15,163 934 621
Urbanized 2,280 2,121 6,826 6,602 6,699 6,398 282 204
Less Urbanized 3,984a 2,797 8,932 7,602 9,234 7,609 531 377
Completely Rural 751b 303 1,843 1,352 1,813 1,155 121 40
POVERTY LEVEL1                
Less Than 100% 13,735 12,382 17,114 16,365 11,216 11,552 2,016 1,801
100-199% 12,319 12,063 27,377 26,080 15,677 16,310 1,243 1,560
200% or More 16,844 17,108 77,796 79,792 82,533 85,139 1,161 1,463
HEALTH INSURANCE2                
Private 16,493 16,774 75,635 75,418 73,980 75,456 1,124 1,235
Medicaid/CHIP 16,381 15,792 24,581 24,797 15,667 16,436 2,071 2,373
Other3 9,704 10,301 29,644 27,739 36,074 38,863 711a 1,128
No Coverage 6,953a 5,729 11,701 11,390 6,913 6,546 1,061 764
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.16B – Serious Financial Worries and Loss of Permanent Housing Because of the COVID-19 Pandemic: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic HOW OFTEN HAD SERIOUS FINANCIAL WORRY BECAUSE OF PANDEMIC Loss of
Permanent
Housing
Because of
Pandemic
(2021)
Loss of
Permanent
Housing
Because of
Pandemic
(2022)
All of the
Time or
Nearly All of
the Time
(2021)
All of the
Time or
Nearly All of
the Time
(2022)
Some of the
Time or
Rarely
(2021)
Some of the
Time or
Rarely
(2022)
Never
(2021)
Never
(2022)
TOTAL 15.6 15.0 44.5 44.2 39.9 40.8 1.6 1.7
GEOGRAPHIC REGION                
Northeast 15.3 14.9 44.3 43.7 40.4 41.4 1.0a 1.6
Midwest 12.9 12.2 44.2 44.7 42.9 43.1 1.6 1.5
South 16.5 16.3 44.4 43.5 39.0 40.3 1.7 1.9
West 16.8 15.5 45.2 45.2 38.1 39.3 1.8 1.8
COUNTY TYPE                
Large Metro 15.3 15.2 45.6 44.2 39.0a 40.6 1.5 1.7
Small Metro 15.7 14.9 44.1 44.5 40.2 40.6 1.5 1.9
Nonmetro 16.6 14.5 41.5 43.3 41.9 42.2 2.2 1.7
Urbanized 14.4 14.0 43.2 43.7 42.4 42.3 1.8 1.3
Less Urbanized 18.0 15.5 40.3 42.2 41.7 42.3 2.4 2.1
Completely Rural 17.0a 10.8 41.8 48.1 41.1 41.1 2.7 1.4
POVERTY LEVEL1                
Less Than 100% 32.7 30.7 40.7 40.6 26.7 28.7 4.7 4.4
100-199% 22.2 22.2 49.4 47.9 28.3 30.0 2.2 2.8
200% or More 9.5 9.4 43.9 43.8 46.6 46.8 0.7 0.8
HEALTH INSURANCE2                
Private 9.9 10.0 45.5 45.0 44.5 45.0 0.7 0.7
Medicaid/CHIP 28.9 27.7 43.4 43.5 27.7 28.8 3.6 4.1
Other3 12.9 13.4 39.3b 36.1 47.8a 50.5 0.9a 1.5
No Coverage 27.2 24.2 45.8 48.1 27.0 27.7 4.1 3.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on their financial worries or loss of permanent housing were excluded from the respective analyses.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.17A – Perceived COVID-19 Pandemic Effect on Access to Medical Care: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Perceived Effect on Access to
Medical Care
Aged 12+
(2021)
Aged 12+
(2022)
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG
TOTAL POPULATION
                           
Appointments moved from
   in-person to telehealth
81,590 82,935 3,508 3,482 78,083 79,453 7,073b 8,033 71,009 71,420 31,772 32,723 39,238 38,697
Delays or cancellations in
   appointments or preventative
   services
66,326 67,645 4,289a 3,888 62,037 63,757 5,802a 6,348 56,235 57,409 24,891 26,117 31,344 31,293
Delays in getting prescriptions 23,300b 25,805 1,613 1,606 21,687b 24,199 2,383b 2,854 19,305a 21,344 9,310b 10,834 9,995 10,510
Unable to access needed care
   resulting in moderate or
   severe impact on health
14,279 15,197 716 726 13,563 14,471 1,460 1,638 12,103 12,833 5,858b 6,931 6,244 5,902
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to medical care did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to medical care were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230720
Table 10.17B – Perceived COVID-19 Pandemic Effect on Access to Medical Care: Among People Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Perceived Effect on Access to
Medical Care
Aged 12+
(2021)
Aged 12+
(2022)
Aged 12-17
(2021)
Aged 12-17
(2022)
Aged 18+
(2021)
Aged 18+
(2022)
Aged 18-25
(2021)
Aged 18-25
(2022)
Aged 26+
(2021)
Aged 26+
(2022)
Aged 26-49
(2021)
Aged 26-49
(2022)
Aged 50+
(2021)
Aged 50+
(2022)
PERCEIVED EFFECT AMONG
TOTAL POPULATION
                           
Appointments moved from
   in-person to telehealth
29.7 29.9 14.2 14.2 31.3 31.4 21.6a 23.5 32.7 32.7 31.5 32.4 33.8 32.9
Delays or cancellations in
   appointments or preventative
   services
24.2 24.4 17.4 15.9 24.8 25.2 17.7 18.6 25.9 26.3 24.7 25.9 27.0 26.6
Delays in getting prescriptions 8.5a 9.3 6.5 6.6 8.7a 9.6 7.3a 8.3 8.9a 9.8 9.2b 10.7 8.6 8.9
Unable to access needed care
   resulting in moderate or
   severe impact on health
5.2 5.5 2.9 3.0 5.4 5.7 4.4 4.8 5.6 5.9 5.8b 6.9 5.4 5.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could report that the questions about access to medical care did not apply to them. Respondents who reported that the respective question did not apply to them were classified as not having experienced that effect.
NOTE: Respondents with unknown information on their perception of the COVID-19 pandemic’s effect on access to medical care were excluded.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

Go to Top of PageGo to the Table of Contents